An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

Marjuki, Henju; Mishin, Vasiliy P.; Chesnokov, Anton P.; De La Cruz, Juan A.; Fry, Alicia M.; Villanueva, Julie; Gubareva, Larisa V.

Back to Previous Page

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

Published Date:

February 25 2014

Source:

J Infect Dis. 2014; 210(3):435-440

Language:

English

[PDF-816.01 KB]

Details:

Alternative Title:

J Infect Dis

Personal Author:

Marjuki, Henju ; Mishin, Vasiliy P. ; Chesnokov, Anton P. ; De La Cruz, Juan A. ; Fry, Alicia M. ; ... More ▼

Description:

Human infections caused by avian influenza A virus type subtype H7N9 have been associated with substantial morbidity and mortality. Emergence of virus variants carrying markers of decreased susceptibility to neuraminidase inhibitors was reported. Here we show that DAS181 (Fludase), an antiviral drug with sialidase activity, potently inhibited replication of wild-type influenza A(H7N9) and its oseltamivir-resistant R292K variants in mice. A once-daily administration initiated early after lethal infection hampered body weight loss and completely protected mice from lethality. We observed a time-dependent effect for 24-72-hour delayed DAS181 treatments on morbidity and mortality. The results warrant further investigation of DAS181 for influenza treatment.

Subject:

[+]

Pubmed ID:

24569063

Pubmed Central ID:

PMC4091581

Document Type:

Journal Article

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

File Type:

Supporting Files:

	jiu105.nxml	text/xml
	jiu10501.gif	image/gif
	jiu10501.jpg	image/jpeg
	jiu10502.gif	image/gif
	jiu10502.jpg	image/jpeg
	supp_210_3_435__index.html	text/html

No Related Documents.

Characterization of Drug-Resistant Influenza A(H7N9) Variants Isolated From an Oseltamivir-Treated Patient in Taiwan

[PDF - 1.04 MB]

Personal Author:

Marjuki, Henju ; Mishin, Vasiliy P. ; ...

Published Date:

August 14 2014

Source:

J Infect Dis. 211(2):249-257

Description:

Background.Patients contracting influenza A(H7N9) infection often developed severe disease causing respiratory failure. Neuraminidase (NA) inhibitors ...

File Type:

[PDF - 1.04 MB]

File Type:

[PDF - 1.04 MB]
R292K Substitution and Drug Susceptibility of Influenza A(H7N9) Viruses

[PDF - 562.27 KB]

Personal Author:

Sleeman, Katrina ; Guo, Zhu ; ...

Published Date:

2013

Source:

Emerg Infect Dis. 19(9):1521-1524.

Description:

Neuraminidase inhibitors are the only licensed antiviral medications available to treat avian influenza A(H7N9) virus infections in humans. According ...

File Type:

[PDF - 562.27 KB]

File Type:

[PDF - 562.27 KB]
An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo

[PDF - 1.06 MB]

Personal Author:

Wilson, Jason R. ; Guo, Zhu ; ...

Published Date:

Oct 03 2016

Source:

Antiviral Res. 135:48-55.

Description:

Zoonotic A(H7N9) avian influenza viruses emerged in China in 2013 and continue to be a threat to human public health, having infected over 800 individ...

File Type:

[PDF - 1.06 MB]

File Type:

[PDF - 1.06 MB]
Enhanced Replication of Highly Pathogenic Influenza A(H7N9) Virus in Humans

[PDF - 2.73 MB]

Personal Author:

Yamayoshi, Seiya ; Kiso, Maki ; ...

Published Date:

Apr 2018

Source:

Emerg Infect Dis. 24(4):746-750.

Description:

To clarify the threat posed by emergence of highly pathogenic influenza A(H7N9) virus infection among humans, we characterized the viral polymerase co...

File Type:

[PDF - 2.73 MB]

File Type:

[PDF - 2.73 MB]
Effect of Live Poultry Market Closure on Avian Influenza A(H7N9) Virus Activity in Guangzhou, China, 2014

[PDF - 611.49 KB]

Personal Author:

Yuan, Jun ; Lau, Eric H.Y. ; ...

Published Date:

Oct 2015

Source:

Emerg Infect Dis. 21(10):1784-1793

Description:

We assessed the effect of closing live poultry markets in China on influenza A(H7N9) virus detection and viability. Intensive sampling was carried out...

File Type:

[PDF - 611.49 KB]

File Type:

[PDF - 611.49 KB]

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

An Investigational Antiviral Drug, DAS181, Effectively Inhibits Replication of Zoonotic Influenza A Virus Subtype H7N9 and Protects Mice From Lethality

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC